ZA9711342B - Method of treating or inhibiting neutropenia - Google Patents
Method of treating or inhibiting neutropeniaInfo
- Publication number
- ZA9711342B ZA9711342B ZA9711342A ZA9711342A ZA9711342B ZA 9711342 B ZA9711342 B ZA 9711342B ZA 9711342 A ZA9711342 A ZA 9711342A ZA 9711342 A ZA9711342 A ZA 9711342A ZA 9711342 B ZA9711342 B ZA 9711342B
- Authority
- ZA
- South Africa
- Prior art keywords
- treating
- neutropenia
- inhibiting
- inhibiting neutropenia
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US77074396A | 1996-12-19 | 1996-12-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA9711342B true ZA9711342B (en) | 1999-06-17 |
Family
ID=25089545
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA9711342A ZA9711342B (en) | 1996-12-19 | 1997-12-17 | Method of treating or inhibiting neutropenia |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0957918A1 (en) |
JP (1) | JP2001506998A (en) |
AR (1) | AR010808A1 (en) |
AU (1) | AU5611398A (en) |
CA (1) | CA2273288A1 (en) |
WO (1) | WO1998026781A1 (en) |
ZA (1) | ZA9711342B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX365321B (en) * | 2012-06-07 | 2019-05-29 | Los Angeles Childrens Hospital | Methods for treating neutropenia using retinoid agonists. |
EP3107533A4 (en) | 2014-02-18 | 2017-10-18 | Children's Hospital Los Angeles | Compositions and methods for treating neutropenia |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2615291B1 (en) * | 1987-05-15 | 1989-07-13 | Thomson Csf | METHOD FOR TESTING OPERATION OF A RADAR INFORMATION DISPLAY DEVICE AND IMPLEMENTATION OF THIS METHOD |
US4916137A (en) * | 1988-02-22 | 1990-04-10 | American Cyanamid Company | 5-(Substituted-amino)-8-(phenyl or substituted-phenyl)-3H,6H-1,4,5A,8A-tetraazaacenaphthylen-3-ones and treatment of neural behavior disorders |
EP0329940B1 (en) * | 1988-02-22 | 1994-01-05 | American Cyanamid Company | 5-(substituted)amino)-8- (phenyl or substituted phenyl)-3H,6H-1,2,5,a,8 a-tetraazaacenaphthylen-3-ones |
-
1997
- 1997-12-17 WO PCT/US1997/023419 patent/WO1998026781A1/en not_active Application Discontinuation
- 1997-12-17 AU AU56113/98A patent/AU5611398A/en not_active Abandoned
- 1997-12-17 CA CA002273288A patent/CA2273288A1/en not_active Abandoned
- 1997-12-17 JP JP52798098A patent/JP2001506998A/en active Pending
- 1997-12-17 EP EP97952527A patent/EP0957918A1/en not_active Withdrawn
- 1997-12-17 ZA ZA9711342A patent/ZA9711342B/en unknown
- 1997-12-18 AR ARP970105989A patent/AR010808A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
CA2273288A1 (en) | 1998-06-25 |
AU5611398A (en) | 1998-07-15 |
JP2001506998A (en) | 2001-05-29 |
AR010808A1 (en) | 2000-07-12 |
EP0957918A1 (en) | 1999-11-24 |
WO1998026781A1 (en) | 1998-06-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA965088B (en) | Methods of preventing or treating allergles | |
EP0771203A4 (en) | Method of treating sweat-related conditions | |
GB9617780D0 (en) | Method of treatment | |
PL331314A1 (en) | Method of treating metallic surfaces | |
ZA9710294B (en) | Method of treating atherosclerosis | |
PL327600A1 (en) | Method of treating depressions | |
GB9605828D0 (en) | Treatment method | |
SG64990A1 (en) | Method of treating polyolefin | |
PL341667A1 (en) | Method of treating cooped | |
EP0938296A4 (en) | Method of treating alopecia | |
GB9618341D0 (en) | Method of treatment | |
ZA973988B (en) | Method of treatment | |
ZA9711342B (en) | Method of treating or inhibiting neutropenia | |
EP0974364A4 (en) | Method of inhibiting drug precipitation | |
IL139943A0 (en) | Method of treatment | |
PL331283A1 (en) | Preparation for treating and/or preventing stupefaction | |
GB2294880B (en) | Method of treating turf | |
GB9415902D0 (en) | Method of treatment | |
GB9407335D0 (en) | Method of treatment | |
GB9600888D0 (en) | Method of treatment | |
GB9822681D0 (en) | Method of treatment | |
GB9414652D0 (en) | Method of treatment | |
GB9602404D0 (en) | Methods of treatment | |
GB9605152D0 (en) | Method of treating inflammation | |
GB9717399D0 (en) | Method of treatment |